Legislative and Regulatory Issues of Interest
AACE Sent a Letter of Support for the Flexibility in Health-IT Reporting Act
AACE sent a letter of support to Representative Renee Ellmers (R-2nd-NC) for introducing the Flexibility in Health-IT Reporting Act (H.R. 270).
AACE Expresses Concerns to HHS and CMS Regarding the Protecting Access to Medicare Act
AACE joined the AMA and other organizations in sending a letter to the Department of Health and Human Services (HHS) and the Centers for Medicare and Medicaid Services (CMS) expressing concerns with the implementation of the Protecting Access to Medicare Act.
New US Surgeon General Congratulated on Confirmation
AACE, as a member of the Diabetes Advocacy Alliance (DAA), sent a letter to Dr. Vivek Murthy congratulating him on his recent confirmation as the 19th Surgeon General of the United States.
AACE and 8 State Chapters Join Societies to Tell Congress to Fix the SGR Now
National AACE and eight AACE state chapters joined other societies in sending a letter to Congress to repeal the Medicare Sustainable Growth Rate (SGR) formula before the expiration of the current payment patch on April 1st.
AACE Sends Letter to CMS Regarding FDA Approved OmniPod Insulin Delivery System
AACE sent a letter to the Centers for Medicare and Medicaid Services (CMS) concerning the current Medicare policy that denies coverage for the OmniPod insulin delivery system.
AACE Urges CMS to Increase Patient Protections in Medicare Advantage Plans
AACE joined the AMA and other organizations in urging the Centers for Medicare and Medicaid Services (CMS) to increase patient protections in the Medicare Advantage plan offerings in the draft 2016 Call Letter and to ensure that an adequate network is available to patients.
AACE Sends a Letter of Support for the Protecting Seniors’ Access to Medicare Act of 2015
The Independent Payment Advisory Board (IPAB) Repeal Coalition, which AACE participates in, sent a letter to Senator John Cornyn, Representative Phil Roe and Representative Linda Sanchez in support of legislation that will repeal the IPAB provision of the Affordable Care Act.
AACE Recommends ONC Modify EHR Certification
AACE has joined the AMA and other medical organizations in recommending that the HHS Office of the National Coordinator for Health Information Technology (ONC) modify current processes of electronic health records (EHR) certification.
Recommendation Sent to USPSTF for an Evidenced-Based Screening Guideline for Abnormal Glucose and Type 2 Diabetes Mellitus in Children and Adolescents
After previously commenting on the United States Preventive Services Task Force (USPSTF)’s Draft Recommendation Statement and Draft Evidence Review for Screening for Abnormal Glucose and Type 2 Diabetes Mellitus, AACE and other members of the Diabetes Advocacy Alliance (DAA) are recommending that the USPSTF now begin an evidence review for a similar guideline applying to children and adolescents.
AACE Urges Congress to Act on Physician Payment Issues During the Lame Duck
AACE has joined other medical specialty organizations to urge congressional leadership to take action on Medicare and Medicaid physician payment and delivery systems during the 2014 lame duck session by enacting the SGR Repeal and Medicare Provider Payment Modernization Act of 2014 (H.R. 4015/S. 2000) and continuing the Medicaid Primary Care Pay Parity program.
AACE Comments on USPSTF Thyroid Dysfunction Screening Recommendations
In a letter to the United States Preventive Services Task Force (USPSTF) regarding their draft thyroid dysfunction screening recommendations, AACE requested more specificity regarding screening effectiveness studies in specific patient populations.
AACE Joins Group to Comment on FDA Framework for Regulatory Oversight of Laboratory Developed Tests
AACE has joined a coalition of state and specialty societies, as well as a number of laboratory directors, to ensure that Food and Drug Administration (FDA) policy regulating laboratory developed testing services does not jeopardize the delivery of health care and that patients continue to have access to medically necessary clinical care.
Broad Coalition of Groups Urge Congress to Pass the National Diabetes Clinical Care Commission Act (H.R. 1074/S. 539)
AACE was joined by organizations representing physicians, allied health professionals, patients, community health organizations and industry in urging Congress to enact the National Diabetes Clinical Care Commission Act (H.R. 1074/S. 539) before the end of this year.
AACE Urges Congress to Repeal the SGR Formula During the 2014 Lame Duck Session
AACE joined a number of organizations in sending a letter to Congressional leaders urging the passage of legislation to repeal the flawed Medicare Sustainable Growth Rate (SGR) formula, reform payment for physicians and other health professionals, and address healthcare “extenders” during the lame duck session of Congress.
AACE Provides Comments to USPSTF Applauding their Expanded Access to Type 2 Diabetes Screening for Adults
AACE sent a comment letter, in conjunction with a previous sign-on letter with the Diabetes Advocacy Alliance, to commend the United States Preventive Services Task Force (USPSTF) for more greatly aligning their type 2 diabetes screening recommendations with AACE guidelines. The letter also recommended that USPSTF modify their discussion of testing methods, list of risk factors, and screening intervals.
Comment Letter on USPSTF’s Draft Recommendation Statement and Draft Evidence Review for Screening for Abnormal Glucose and Type 2 Diabetes Mellitus
AACE, as a member of the Diabetes Advocacy Alliance (DAA), provided comments regarding the United States Preventive Services Task Force (USPSTF)’s Draft Recommendation Statement and Draft Evidence Review for Screening for Abnormal Glucose and Type 2 Diabetes Mellitus and, in particular, suggested modifying risk factors to better identify adults at increased risk for diabetes and to clarify the terms used under screening intervals recommendations.
Letter of Support Sent to Rep. Burgess for Sponsoring Legislation to Clarify Sunshine Act Reporting
AACE joined a number of medical organizations in sending a letter to Rep. Michael Burgess, MD (R-26-TX) supporting his introduction of H.R. 5539, which will clarify that certain applicable manufacturer transfers of value to support independent medical educational programs and materials are exempt from reporting under the Physician Payments Sunshine Act (Sunshine Act).
AACE Urges Congress to Address Important Glucose Monitoring Issues
AACE sent a letter to Congress, based on conclusions from the Glucose Monitoring Consensus Conference in Washington, DC, that outlines three actions Congress can take to improve care for patients with diabetes.
Letter of Support Sent to Cosponsors of the Ensuring Access to Primary Care for Women & Children Act
AACE joined eighteen other groups in sending a letter applauding Senators Sherrrod Brown (D-OH) and Patty Murray (D-WA) for introducing S. 2694, the Ensuring Access to Primary Care for Women & Children Act, which will extend current-law payment rates under Medicaid for certain primary care and immunization services to at least the level of Medicare through 2016.
AACE Submits Comments Addressing the Sunshine Act Provisions in the 2015 Medicare Physician Fee Schedule Proposed Rule
AACE submitted a comment letter to the Centers for Medicare and Medicaid Services’ proposed 2015 Medicare physician payment policy specifically addressing the Open Payments (Sunshine Act) provisions.
AACE Submits Comments on the 2015 Medicare Physician Fee Schedule Proposed Rule
AACE submitted a comment letter to the Centers for Medicare and Medicaid Services on the proposed changes in the Medicare physician payment policy for calendar year 2015.
2015 Medicare Physician Fee Schedule Proposed Rule Comment Letter Focuses on Diabetes
AACE, as a member of the Diabetes Advocacy Alliance (DAA), provided comments on the 2015 Medicare Physician Fee Schedule proposed rule with a specific focus to diabetes-related recommendations.
AACE Joins Physician Biologics Prescribers Group in Letter to FDA Regarding Naming of Biosimilars
AACE joined 10 other physician organizations to comment on the implementation of the Biologics Price Competition and Innovation Act (BPCIA) and the need for distinguishable naming of biosimilar products.
CMS Urged to Extend Sunshine Act Review Period
AACE, along with over 100 state and medical specialty societies, signed on to a letter drafted by the American Medical Association (AMA) requesting that CMS simplify the physician registration process for the Open Payments database and extend the deadline to review and dispute industry reports. The letter also addresses a proposal to eliminate the Open Payments reporting exception for faculty payments at accredited continuing medical education (CME) events.
Sunshine Act Stakeholders Comment to CMS on Onerous Open Payments Registration Process
In a letter circulated by the Pharmaceutical Research and Manufacturers of America (PhRMA), with input from over 20 organizations, including AACE, CMS was asked to increase physician education and outreach and to simplify the registration process for the Sunshine Act (Open Payments) database. The letter also seeks clarification on how CMS plans to educate the public and provide context for Open Payments reports.
AACE Comments on USPSTF draft recommendation “Behavioral Counseling to Promote a Healthy Diet and Physical Activity for Cardiovascular Disease (CVD) Prevention in Adults with Known Risk Factors”
AACE, as a member of the Diabetes Advocacy Alliance (DAA), sent a comment letter on the United States Preventive Services Task Force’s (USPSTF) draft recommendation statement on “Behavioral Counseling to Promote a Healthy Diet and Physical Activity for CVD Prevention in Adults with Known Risk Factors” urging that the final recommendation improve the relative CVD risk for overweight and obese people.
AACE Comments on EPA Policy on Environmental Justice for Tribes and Indigenous Peoples
AACE, as a member of the Diabetes Advocacy Alliance (DAA), sent a comment letter to the US Environmental Protection Agency (EPA) on its Policy on Environmental Justice for Tribes and Indigenous Peoples, noting that diabetes care and prevention related to environmental justice concerns are not reflected.